Agnès Montagne

Randomized, double-blind, placebo-controlled study of F17464, a preferential D3 antagonist, in the treatment of acute exacerbation of schizophrenia

István Bitter, Jeffrey A. Lieberman, Florence Gaudoux et al. · Neuropsychopharmacology · 2019 · 33 citations · Full text

Preferential D3 Antagonist, Psychiatry, Psychotic Disorder +11

Longterm Therapeutic Response to Milnacipran Treatment for Fibromyalgia. A European 1-Year Extension Study Following a 3-Month Study

Jaime Branco, P. Chérìn, Agnès Montagne et al. · The Journal of Rheumatology · 2011 · 29 citations · Full text

Pain relief of sore throat with a new anti-inflammatory throat lozenge, ibuprofen 25 mg: A randomised, double-blind, placebo-controlled, international phase III study

Athmane Bouroubi, Yves Donazzolo, Franck Donath et al. · International Journal of Clinical Practice · 2017 · 17 citations · Full text

Binding of the D3-preferring antipsychotic candidate F17464 to dopamine D3 and D2 receptors: a PET study in healthy subjects with [11C]-(+)-PHNO

Mark Slifstein, Anissa Abi‐Dargham, Ragy R. Girgis et al. · Psychopharmacology · 2019 · 16 citations

Healthy Subjects, Psychiatry, Medicine +9

Ferrous sulfate oral solution in young children with iron deficiency anemia: An open‐label trial of efficacy, safety, and acceptability

Lidia Pachuta Węgier, Maciej Kubiak, Agata Liebert et al. · Pediatrics International · 2020 · 14 citations · Full text